Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality
by
Elberling, Frederik
, Magyari, Melinda
, Koch‐Henriksen, Nils
in
Adult
/ Age of Onset
/ Autoimmune diseases
/ Comorbidity
/ Denmark - epidemiology
/ Female
/ Humans
/ Male
/ Middle Aged
/ Mortality
/ Multiple sclerosis
/ Multiple Sclerosis - mortality
/ multiple sclerosis excess mortality
/ Multiple Sclerosis, Chronic Progressive - mortality
/ Multiple Sclerosis, Relapsing-Remitting - mortality
/ Original
/ Phenotype
/ Phenotypes
/ Populations
/ primary progressive multiple sclerosis
/ Registries
/ relapsing onset multiple sclerosis
/ secondary progressive multiple sclerosis
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality
by
Elberling, Frederik
, Magyari, Melinda
, Koch‐Henriksen, Nils
in
Adult
/ Age of Onset
/ Autoimmune diseases
/ Comorbidity
/ Denmark - epidemiology
/ Female
/ Humans
/ Male
/ Middle Aged
/ Mortality
/ Multiple sclerosis
/ Multiple Sclerosis - mortality
/ multiple sclerosis excess mortality
/ Multiple Sclerosis, Chronic Progressive - mortality
/ Multiple Sclerosis, Relapsing-Remitting - mortality
/ Original
/ Phenotype
/ Phenotypes
/ Populations
/ primary progressive multiple sclerosis
/ Registries
/ relapsing onset multiple sclerosis
/ secondary progressive multiple sclerosis
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality
by
Elberling, Frederik
, Magyari, Melinda
, Koch‐Henriksen, Nils
in
Adult
/ Age of Onset
/ Autoimmune diseases
/ Comorbidity
/ Denmark - epidemiology
/ Female
/ Humans
/ Male
/ Middle Aged
/ Mortality
/ Multiple sclerosis
/ Multiple Sclerosis - mortality
/ multiple sclerosis excess mortality
/ Multiple Sclerosis, Chronic Progressive - mortality
/ Multiple Sclerosis, Relapsing-Remitting - mortality
/ Original
/ Phenotype
/ Phenotypes
/ Populations
/ primary progressive multiple sclerosis
/ Registries
/ relapsing onset multiple sclerosis
/ secondary progressive multiple sclerosis
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality
Journal Article
The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality
2025
Request Book From Autostore
and Choose the Collection Method
Overview
Background Patients With Multiple Sclerosis (MS) Have Higher Mortality Than Matched Background Populations. We Compare Relative and Excess Mortality in MS Over the Matched Background Populations Between Primary Progressive MS (PPMS), relapsing Onset MS (ROMS), and Secondary Progressive MS (SPMS). Methods We included all patients from the nationwide and complete Danish MS Registry with onset 1994–2022 and compared the extra mortality of the MS phenotypes in terms of relative and excess mortality, with adjustment for sex, age at onset, disease‐modifying treatment, and number of recorded relapses. We calculated the adjusted ratios of relative and excess mortalities between PPMS and ROMS and between PPMS and SPMS. Results The initial course was unknown in 221, leaving 1412 cases with PPMS (which includes progressive relapsing MS) and 12,449 cases with ROMS. 627 had died during follow‐up by the end of 2022. After adjustment, both ratios between PPMS and ROMS came close to unity, indicating that the excess mortality is equal for PPMS and ROMS in the long run. The adjusted relative and additive mortalities were factors 6.05 (95% CI 4.42–8.27) and 1.90 (95% CI 1.65–2.18) higher in SPMS than in PPMS. Conclusions Compared with the matched population, the adjusted relative and excess mortalities are the same for PPMS and ROMS. However, SPMS had a higher relative and excess mortality than PPMS, probably in part owing to the burden of disease carried over from the pre‐progressive phase. This underlines the need for effective treatment in this later stage of the disease and more attention to comorbidity.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
This website uses cookies to ensure you get the best experience on our website.